| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |